| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021214 |
| Receipt No. | R000024461 |
| Official scientific title of the study | Clinical factors of hyperglycemia in children after surgery for congenital heart disease and thier prognosis |
| Date of disclosure of the study information | 2016/02/26 |
| Last modified on | 2019/01/24 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Clinical factors of hyperglycemia in children after surgery for congenital heart disease and thier prognosis | |
| Title of the study (Brief title) | Hyperglycemia after surgery for congenital heart disease | |
| Region |
|
|
| Condition | ||||||
| Condition | Congenital heart diseases which underwent open heart surgery | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | Hyperglycemia after congenital heart disease in infants and children are reported to be related with worse outcomes. Opposit reports, on the other hand, also exist. Some reports show faictors contributing to hyperglycemia, but that is still uncertain.
This study is aimed to investigate clinical factors related to hyperglycemia and the effects of hyperglycemia on clinical outcomes. |
| Basic objectives2 | Others |
| Basic objectives -Others | Hyperglycemia after congenital heart disease in infants and children are reported to be related with worse outcomes. Opposit reports, on the other hand, also exist. Some reports show faictors contributing to hyperglycemia, but that is still uncertain.
This study is aimed to investigate clinical factors related to hyperglycemia and the effects of hyperglycemia on clinical outcomes. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Background clinical status, length of postoperative mechanical ventilation and length of ICU stay are compared betweenn patients with hyperglycemia and euglycemia. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent cardiac surgery for congenital heart diseases using cardiopulmonary bypass at the age of 1 month to 15 years and who were admitted to intensive care unit after the surgery. | |||
| Key exclusion criteria | Patients who died soon after the surgry and needed mechanical ventilation more than 2 weeks after the surgery were excluded. | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Shunsuke Takaki |
| Organization | Yokohama City University |
| Division name | Intensive Care Unit |
| Address | Fukuura3-9, Yokohama, Japan |
| TEL | 045-787-2800 |
| anesthes@yokohama-cu.ac.jp | |
| Public contact | |
| Name of contact person | Natsuhiro Yamamoto |
| Organization | Yokohama City University |
| Division name | Intensive Care Unit |
| Address | Fukuura3-9, Yokohama, Japan |
| TEL | 045-787-2800 |
| Homepage URL | |
| anesthes@yokohama-cu.ac.jp | |
| Sponsor | |
| Institute | Department of Anaesthesiology and Intensive Care Unit, Yokohama City University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | Hyperglycemia is defined as blood glucose over 250mg/dL and below it is defined as euglycemia. Preoperative factors such as age, height, body weight, past medical history and chromosomal abnormality are reviewed. In addition, operative factors (operative time, cardiopulmonary time, anesthetic factors,labo data and vital sighns) and postoperative factors (length of mechanical ventilation, length of ICU stay and vital sighns) are also corrected. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024461 |